129 related articles for article (PubMed ID: 8383188)
1. Anticholinesterase-responsive neuromuscular junction transmission defects in post-poliomyelitis fatigue.
Trojan DA; Gendron D; Cashman NR
J Neurol Sci; 1993 Feb; 114(2):170-7. PubMed ID: 8383188
[TBL] [Abstract][Full Text] [Related]
2. Stimulation frequency-dependent neuromuscular junction transmission defects in patients with prior poliomyelitis.
Trojan DA; Gendron D; Cashman NR
J Neurol Sci; 1993 Sep; 118(2):150-7. PubMed ID: 8229063
[TBL] [Abstract][Full Text] [Related]
3. An open trial of pyridostigmine in post-poliomyelitis syndrome.
Trojan DA; Cashman NR
Can J Neurol Sci; 1995 Aug; 22(3):223-7. PubMed ID: 8529175
[TBL] [Abstract][Full Text] [Related]
4. Anticholinesterases in post-poliomyelitis syndrome.
Trojan DA; Cashman NR
Ann N Y Acad Sci; 1995 May; 753():285-95. PubMed ID: 7611637
[No Abstract] [Full Text] [Related]
5. Myasthenic syndrome studied with single fiber electromyography.
Schwartz MS; Stålberg E
Arch Neurol; 1975 Dec; 32(12):815-7. PubMed ID: 173269
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular transmission as a function of motor unit size in patients with prior poliomyelitis.
Maselli RA; Cashman NR; Wollman RL; Salazar-Grueso EF; Roos R
Muscle Nerve; 1992 Jun; 15(6):648-55. PubMed ID: 1324424
[TBL] [Abstract][Full Text] [Related]
7. Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.
Horemans HL; Nollet F; Beelen A; Drost G; Stegeman DF; Zwarts MJ; Bussmann JB; de Visser M; Lankhorst GJ
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1655-61. PubMed ID: 14638885
[TBL] [Abstract][Full Text] [Related]
8. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
Donati F; Ferguson A; Bevan DR
Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
[TBL] [Abstract][Full Text] [Related]
9. Pyridostigmine toxicity. Electrophysiological study.
Park KH; Kim DE; Arnold TW; Oh SJ; Bradley R
Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):323-8. PubMed ID: 8223330
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome.
Trojan DA; Collet JP; Shapiro S; Jubelt B; Miller RG; Agre JC; Munsat TL; Hollander D; Tandan R; Granger C; Robinson A; Finch L; Ducruet T; Cashman NR
Neurology; 1999 Oct; 53(6):1225-33. PubMed ID: 10522877
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
Gyermek L; Cantley EM; Lee C
Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
[TBL] [Abstract][Full Text] [Related]
12. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis associated with defects in neuromuscular transmission.
Patten BM; Hart A; Lovelace R
J Neurol Neurosurg Psychiatry; 1972 Jun; 35(3):385-94. PubMed ID: 4338448
[TBL] [Abstract][Full Text] [Related]
14. Correlation of electrophysiology with pathology, pathogenesis, and anticholinesterase therapy in post-polio syndrome.
Cashman NR; Trojan DA
Ann N Y Acad Sci; 1995 May; 753():138-50. PubMed ID: 7611623
[No Abstract] [Full Text] [Related]
15. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
Ferguson A; Egerszegi P; Bevan DR
Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular transmission in myasthenia gravis studied with single fibre electromyography.
Stålberg E; Ekstedt J; Broman A
J Neurol Neurosurg Psychiatry; 1974 May; 37(5):540-7. PubMed ID: 4366058
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular actions of edrophonium in the lateral segmental tail muscle of the rat in vivo.
Whittaker R
J Pharm Pharmacol; 1975 Jun; 27(6):420-4. PubMed ID: 237090
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.
Barber HE; Calvey TN; Muir KT
Br J Pharmacol; 1979 Aug; 66(4):525-30. PubMed ID: 223706
[TBL] [Abstract][Full Text] [Related]
19. A congenital myasthenic syndrome refractory to acetylcholinesterase inhibitors.
Triggs WJ; Beric A; Butler IJ; Roongta SM
Muscle Nerve; 1992 Mar; 15(3):267-72. PubMed ID: 1313543
[TBL] [Abstract][Full Text] [Related]
20. AAEE minimonograph #25: Single-fiber electromyography in myasthenia gravis.
Sanders DB; Howard JF
Muscle Nerve; 1986; 9(9):809-19. PubMed ID: 3785290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
